<resources>
    <string name="app_name">AdrRepoting</string>
    <string name="q11op1">Should be in every hospital</string>
    <string name="q11op2">Not necessary in every hospital</string>
    <string name="q11op3">One in a city is sufficient</string>
    <string name="q11op4">Depends on number of bed size in the hospitals</string>
    <string name="q13op3">Don\'t know where to submit the ADR reporting form</string>
    <string name="q13op4">Don\'t know how to fill up the ADR reporting form</string>
    <string name="q15op3">Don\'t know about online reporting system or mobile application software</string>
    <string name="q15op4">Don\'t know how to use the online system or mobile application software</string>
    <string name="q17op1">One day</string>
    <string name="q17op2">Seven calendar days</string>
    <string name="q17op3">Fourteen calendar days</string>
    <string name="q17op4">Fifteen</string>
    <string name="q18op1">During phase-1 clinical trials</string>
    <string name="q18op2">During phase-2 clinical trials</string>
    <string name="q18op3">During phase-3 clinical trials</string>
    <string name="q18op4">During phase-4 clinical trials</string>
    <string name="q19op3">Not yet formed</string>
    <string name="q19op4">Don\'t know</string>
    <string name="q1op1">The science detecting the type and incidence of ADR after drug is marketed</string>
    <string name="q1op2">The science of monitoring ADR\'s occurring in a Hospital</string>
    <string name="q1op3">The process of improving the safety of the drug</string>
    <string name="q1op4">The detection, assessment, understanding and prevention of adverse effects</string>
    <string name="q20op1">No remuneration</string>
    <string name="q20op2">Lack of time to report ADR</string>
    <string name="q20op3">A single unreported case may not affect ADR database</string>
    <string name="q20op4">Difficult to decide whether ADR has occurred or not</string>
    <string name="q2op1">To identify safety of the drug</string>
    <string name="q2op2">To calculate incidence of ADRs</string>
    <string name="q2op3">To identify predisposing factors to ADR\'s</string>
    <string name="q2op4">To identify previously unrecognized ADR\'s</string>
    <string name="q4op1">Doctor</string>
    <string name="q4op2">Nurses</string>
    <string name="q4op3">Pharmacist</string>
    <string name="q4op4">All</string>
    <string name="q6op1">Bangladesh Medical and Dental Council (BMDC)</string>
    <string name="q6op2">Directorate General of Drug Administration (DGDA)</string>
    <string name="q6op3">Ministry of Health and Family Welfare (MHFW)</string>
    <string name="q6op4">Bangladesh Department of Narcotics Control (DNC)</string>
    <string name="q7op1">Unites States of America</string>
    <string name="q7op2">United Kingdom</string>
    <string name="q7op3">France</string>
    <string name="q7op4">Sweden</string>
    <string name="yes">Yes</string>
    <string name="maybe">May be</string>
    <string name="mcq1">1. Define Pharmacovigilance.</string>
    <string name="mcq10">10. Have you anytime read any article on prevention of adverse drug reactions?</string>
    <string name="mcq11">11. What is your opinion about establishing ADR monitoring centre in every hospital?</string>
    <string name="mcq12">12. Have you ever experienced adverse drug reactions in your patient during your professional practice?</string>
    <string name="mcq13">13. Have you ever reported ADR to the Pharmacovigilance centre?</string>
    <string name="mcq14">14. Have you ever seen the ADR reporting form?</string>
    <string name="mcq15">15. Do you think online system or mobile application software will make the reporting system easy ?</string>
    <string name="mcq16">16. Have you ever been trained on how to report Adverse Drug Reaction (ADR)?</string>
    <string name="mcq17">17. A serious adverse event in Bangladesh should be reported to the regulatory body within</string>
    <string name="mcq18">18. Rare ADRs can be identified in the following phase of a clinical trial</string>
    <string name="mcq19">19. Is there any Pharmacovigilance Committee in your Institute?</string>
    <string name="mcq2">2. The most important purpose of Pharmacovigilance is</string>
    <string name="mcq20">20. Which of the following factor discourage you from reporting ADRs?</string>
    <string name="mcq3">3. Do you think ADR reporting is professional obligation for you?</string>
    <string name="mcq4">4. The healthcare professionals responsible for reporting ADRs in a hospital is/are</string>
    <string name="mcq5">5. Do you know regarding the existence of a National Pharmacovigilance Programme in Bangladesh?</string>
    <string name="mcq6">6. In Bangladesh which regulatory body is responsible for monitoring ADRs?</string>
    <string name="mcq7">7. Where the international center for adverse drug reaction monitoring is located?</string>
    <string name="mcq8">8. Do you think reporting of adverse drug reaction is necessary?</string>
    <string name="mcq9">9. Do you think Pharmacovigilance should be taught in detail to healthcare professionals?</string>
    <string name="multiLine">Describe event including relevant \n tests and laboratory results:</string>
    <string name="no">No</string>
    <string name="cantsay">Can\'t say</string>
</resources>
